These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
659 related articles for article (PubMed ID: 20728393)
1. [Quality of life after radiotherapy for prostate cancer]. Joly F; Degrendel AC; Guizard AV Cancer Radiother; 2010 Oct; 14(6-7):519-25. PubMed ID: 20728393 [TBL] [Abstract][Full Text] [Related]
2. Cross-sectional survey of long-term quality of life after radical perineal prostatectomy. Yang BK; Crisci A; Young MD; Silverstein AD; Peterson BL; Dahm P Urology; 2005 Jan; 65(1):120-5. PubMed ID: 15667876 [TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer. Forsythe K; Blacksburg S; Stone N; Stock RG Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032 [TBL] [Abstract][Full Text] [Related]
4. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305 [TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F; Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680 [TBL] [Abstract][Full Text] [Related]
6. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365 [TBL] [Abstract][Full Text] [Related]
7. [Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: The Hotel-Dieu of Quebec experience]. Zebentout O; Apardian R; Beaulieu L; Harel F; Martin AG; Vigneault E Cancer Radiother; 2010 Jun; 14(3):183-8. PubMed ID: 20418145 [TBL] [Abstract][Full Text] [Related]
8. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy. Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108 [TBL] [Abstract][Full Text] [Related]
9. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568 [TBL] [Abstract][Full Text] [Related]
10. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. Walsh PC J Urol; 2000 Jun; 163(6):1802-7. PubMed ID: 10799186 [TBL] [Abstract][Full Text] [Related]
11. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer. Bradley EB; Bissonette EA; Theodorescu D BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117 [TBL] [Abstract][Full Text] [Related]
12. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. Nieder AM; Porter MP; Soloway MS J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517 [TBL] [Abstract][Full Text] [Related]
13. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life. Morton GC; Loblaw DA; Sankreacha R; Deabreu A; Zhang L; Mamedov A; Cheung P; Keller B; Danjoux C; Szumacher E; Thomas G Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):811-7. PubMed ID: 19836166 [TBL] [Abstract][Full Text] [Related]
14. [Sexual dysfunctions after prostate cancer radiation therapy]. Droupy S Cancer Radiother; 2010 Oct; 14(6-7):504-9. PubMed ID: 20728392 [TBL] [Abstract][Full Text] [Related]
15. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up. Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F; Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168 [TBL] [Abstract][Full Text] [Related]
16. Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy. Staff I; Salner A; Bohannon R; Panatieri P; Maljanian R Cancer; 2003 Dec; 98(11):2335-43. PubMed ID: 14635067 [TBL] [Abstract][Full Text] [Related]
17. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471 [TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: comparison with conventional and conformal radiotherapy. Namiki S; Ishidoya S; Tochigi T; Kawamura S; Kuwahara M; Terai A; Yoshimura K; Numata I; Satoh M; Saito S; Takai Y; Yamada S; Arai Y Jpn J Clin Oncol; 2006 Apr; 36(4):224-30. PubMed ID: 16537689 [TBL] [Abstract][Full Text] [Related]
19. Responsiveness of the University of California-Los Angeles Prostate Cancer Index. Bergman J; Saigal CS; Kwan L; Litwin MS Urology; 2010 Jun; 75(6):1418-23. PubMed ID: 19589573 [TBL] [Abstract][Full Text] [Related]
20. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T; Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]